Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data (Q28943545)

14 March 2017

title

Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data (English)

1 reference

14 March 2017

1 reference

Sonja Scholz

2

0 references

Katrina Gwinn

object named as

Katrina Gwinn-Hardy

18

0 references

Michael S. Okun

11

object named as

Michael S. Okun

1 reference

14 March 2017

14

Kelly D. Foote

1 reference

14 March 2017

19

John A. Hardy

1 reference

Fabienne Wavrant De Vrieze

14 March 2017

17

object named as

Fabienne Wavrant De Vrieze

1 reference

14 March 2017

13

Hubert H. Fernandez

1 reference

14 March 2017

20

Andrew Singleton

1 reference

14 March 2017

8

Carl Langefeld

1 reference

14 March 2017

5

Dena Hernandez

1 reference

14 March 2017

4

Javier Simón-Sánchez

1 reference

14 March 2017

7

J. Raphael Gibbs

1 reference

14 March 2017

6

Angela Britton

1 reference

14 March 2017

Hon-Chung Fung

1

1 reference

14 March 2017

Mar Matarin

3

1 reference

14 March 2017

Matt L. Stiegert

9

1 reference

14 March 2017

Jennifer Schymick

10

1 reference

14 March 2017

Ronald J. Mandel

12

1 reference

14 March 2017

Ramón L. Rodríguez

15

1 reference

14 March 2017

Elizabeth Peckham

16

1 reference

14 March 2017

language of work or name

1 reference

1 November 2006

1 reference

14 March 2017

1 reference

14 March 2017

volume

5

1 reference

14 March 2017

issue

11

1 reference

14 March 2017

page(s)

911–916

1 reference

Changing epidemiology of Parkinson's disease in southwestern Finland

14 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

The International HapMap Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

A haplotype map of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

High-resolution whole-genome association study of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Genomewide association, Parkinson disease, and PARK10

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Complement factor H polymorphism in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970578-6

7 January 2021

10.1016/S1474-4422(06)70578-6

Identifiers

DOI

1 reference

14 March 2017

1 reference